FdaApplication
ANDA 077494
Identifiers
- fda_app_no: ANDA077494
Properties
| Property | Value |
|---|---|
| applicant_name | PH HEALTH LTD |
| application_type | ANDA |
| approval_date | 2009-04-30 |
Products (7)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RISPERIDONE | RISPERIDONE | 0.25MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| RISPERIDONE | RISPERIDONE | 1MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| RISPERIDONE | RISPERIDONE | 2MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| RISPERIDONE | RISPERIDONE | 3MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| RISPERIDONE | RISPERIDONE | 1MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| RISPERIDONE | RISPERIDONE | 4MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| RISPERIDONE | RISPERIDONE | 0.5MG | TABLET, ORALLY DISINTEGRATING;ORAL |
7 products